Pharmaceutical Industries | Zee News

Advertisement

NewsPharmaceutical Industries

Pharmaceutical Industries News

Lupin Pharmaceuticals

17 Aug 2016

Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Mumbai-based Lupin Pharmaceuticals is India`s most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.

27 Jun 2016

42 essential medicines to be cheaper by up to 15%: NPPA

Prices of 42 essential medicines used in treatment of various ailments including tuberculosis, cancer, cardiac diseases, asthma, epilepsy, rheumatoid arthritis and depression have been capped by the government, reducing their cost by up to 15 percent.

20 Jun 2016

FDI up to 74% in brownfield pharma under automatic route

The government today allowed up to 74 percent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector.

Kiran Mazumdar-Shaw

06 Apr 2016

Give exemption from drug price control for 5 years: Mazumdar-Shaw

Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.

15 Mar 2016

After Pfizer, HC grants relief to Abbott and Macleods

Pharma majors Abbott Healthcare and Macleods Pharmaceuticals Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.

10 Feb 2016

Cipla Q3 net profit rises 4.68% to Rs 343.20 crore

Pharmaceutical firm Cipla Ltd Wednesday reported 4.68 percent increase in its consolidated net profit at Rs 343.20 crore in the third quarter ended December 2015.

Medicine prices

07 Feb 2016

'Withdrawing customs duty may lead to hike in medicine prices'

The government's move to withdraw customs duty exemption on imports of around 74 drugs would help in local production of bulk drugs and thereby create demand for the local production but it may also lead to rise in prices for these medicines.

29 Nov 2015

Govt in talks with various markets to accept Indian drug norms

India is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms, a move aimed at helping many Indian drug makers to save cost on upgrading to international standards.

Dr Reddy's Laboratories

26 Nov 2015

USFDA gives Dr Reddy's addl time to respond to warning letter

Dr Reddy's Laboratories Ltd (DRL) Thursday said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7.

Dr Reddy's Laboratories

29 Oct 2015

Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore

Aided by good sales growth coupled with new product launches, drug major Dr Reddy's Laboratories Thursday reported a 25.74 percent jump in consolidated net profit at Rs 721.89 crore for the second quarter ended September 30.

28 Oct 2015

Novartis gets USFDA warning letter for two plants in India

Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of current good manufacturing practice (cGMP) norms at its two plants in Western India.

26 Oct 2015

Lupin appoints Martin Mercer as head of Latin American biz

Drug major Lupin Monday appointed Martin Mercer as President of its Latin American business with immediate effect.

20 Oct 2015

Cipla's Indore plant under USFDA scanner over norms violations

Pharmaceutical major Cipla's shares dropped by 2.13 percent Tuesday amid speculation that the company's Indore plant has come under the scanner of US health regulator for manufacturing norms violations.

Pharmaceutical Industries

11 Oct 2015

Govt to commission study on impact of FDI in pharma

The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.

Sun Pharmaceutical Industries

29 Sep 2015

Sun Pharma makes tender offer to acquire InSite Vision

Drug major Sun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.

Glenmark Pharmaceuticals

22 Sep 2015

Glenmark Pharma eyes US biz to be strong growth driver

Glenmark Pharmaceuticals Tuesday said it is looking at strong growth in the US market and developing a pipeline of innovative products to offset weakness in emerging markets.

18 Aug 2015

Govt assures all help to boost pharma exports

Government Tuesday assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made to expedite work on different proposals to realise the full potential of the sector.

05 Aug 2015

India defers FTA talks with EU over ban of 700 pharma products

Expressing disappointment and concern over the EU banning sale of around 700 pharma products clinically tested by GVK Biosciences, India has deferred the talks with the European Union on the proposed free trade agreement.

SRL Diagnostics

02 Aug 2015

SRL lines up Rs 100 crore to add 100 labs by 2016-end

Leading laboratory network SRL Diagnostics is planning to invest around Rs 100 crore to add 100 labs across the country by the end of 2016 as part of its expansion plan.

Pharmaceutical Industries

28 Jul 2015

Hikma buys US generic drugmaker Roxane for $2.65bn

London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector`s latest rapid round of consolidation.

Loading...

NEWS ON ONE CLICK